Clinical implications of the BRAVO and CRUISE trials: How should physicians apply this new information in their treatment of CRVO and BRVO?

David M. Brown

Clinical implications of the BRAVO and CRUISE trials: How should physicians apply this new information in their treatment of CRVO and BRVO?

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	38-40
Number of pages	3
Journal	Retina Today
Issue number	APRIL
State	Published - Apr 1 2010

ASJC Scopus subject areas

Ophthalmology

Cite this

@article{4ee27a81ba3e467db48a15b142255734,

title = "Clinical implications of the BRAVO and CRUISE trials: How should physicians apply this new information in their treatment of CRVO and BRVO?",

author = "Brown, {David M.}",

year = "2010",

month = apr,

day = "1",

language = "English (US)",

pages = "38--40",

journal = "Retina Today",

issn = "1825-0572",

publisher = "Bryn Mawr Communications LLC",

number = "APRIL",

}

TY - JOUR

T1 - Clinical implications of the BRAVO and CRUISE trials

T2 - How should physicians apply this new information in their treatment of CRVO and BRVO?

AU - Brown, David M.

PY - 2010/4/1

Y1 - 2010/4/1

UR - http://www.scopus.com/inward/record.url?scp=79952991352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952991352&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79952991352

SP - 38

EP - 40

JO - Retina Today

JF - Retina Today

SN - 1825-0572

IS - APRIL

ER -

Clinical implications of the BRAVO and CRUISE trials: How should physicians apply this new information in their treatment of CRVO and BRVO?

ASJC Scopus subject areas

Other files and links

Cite this